mavorixafor will increase the level or effect of codeine by affecting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a solid CYP2D6 inhibitor) is contraindicated with medications which have been remarkably depending on CYP2D6 for clearance.Since 2019, there are increasing experiences inside the media of codeine linctus remaining mi